Uterine Corpus Cancer: Clinical Trials

8 trials for Uterine Corpus Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 active not recruiting, 2 terminated, 1 not yet recruiting. 3 Phase 2, 2 Not applicable, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Terminated 1
Not applicable2Completed 1, Terminated 1
Early Phase 11Active not recruiting 1

Follow Uterine Corpus Cancer: new trials by email Literature Review of Uterine Corpus Cancer trials Research Report on Uterine Corpus Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy
Baseline 89-Zr Pembrolizumab Immuno PET-CT, Proteomic assay, Follow-up 89-Zr Pembrolizumab Immuno PET-CT - Triple Negative Breast Cancer, Uterine Cervical Cancer
Phase 2Not yet recruitingMaria Sklodowska-Curie National Research Institute of Oncology602025-06-012025-05-16
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
Questionnaire Administration - Endometrial Carcinoma, Malignant Uterine Neoplasm
Active not recruitingM.D. Anderson Cancer Center3102020-01-092026-05-20
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Computed Tomography, Gallium Ga 68 FAPi-46, Gallium Ga 68-labeled PSMA-11 - Breast Carcinoma, Colon Carcinoma
Early Phase 1Active not recruitingJonsson Comprehensive Cancer Center292019-11-052026-08-21
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Bupropion 150 mg XL, Placebo - Breast Carcinoma, Cervical Carcinoma
Phase 2CompletedNRG Oncology2302017-05-312026-07-10
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Metformin Hydrochloride, Doxycycline - Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2TerminatedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University292016-06-082026-04-22
Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers
Supportive Care, Quality-of-Life Assessment, Questionnaire Administration - Cervical Carcinoma, Ovarian Carcinoma
Not applicableTerminatedCity of Hope Medical Center32015-07-232026-10-20
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Palliative Therapy, Palliative Therapy + idiographic - Cervical Carcinoma, Ovarian Carcinoma
Not applicableCompletedAlbert Einstein College of Medicine952015-04-012019-09-17
Collecting Tumor Samples From Patients With Gynecological Tumors
Laboratory Biomarker Analysis - Borderline Ovarian Clear Cell Tumor, Borderline Ovarian Serous Tumor
CompletedGynecologic Oncology Group2751992-06-012016-10-28

Narrower conditions

Ovarian Neoplasms (5)  ·  Uterine Cervical Neoplasms (5)  ·  Vulvar Neoplasms (4)  ·  Breast Neoplasms (3)  ·  Vaginal Neoplasms (3)  ·  Carcinoma, Renal Cell (2)  ·  Melanoma (2)  ·  Brenner Tumor (1)  ·  Colonic Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Gestational Trophoblastic Disease (1)  ·  Lung Neoplasms (1)  ·  Mesothelioma, Malignant (1)

Broader conditions

Neoplasms (8)  ·  Neoplasms by Site (8)  ·  Female Urogenital Diseases (7)  ·  Female Urogenital Diseases and Pregnancy Complications (7)  ·  Genital Diseases (7)  ·  Genital Diseases, Female (7)  ·  Genital Neoplasms, Female (7)  ·  Urogenital Diseases (7)  ·  Urogenital Neoplasms (7)  ·  Uterine Diseases (6)  ·  Adnexal Diseases (5)  ·  Endocrine Gland Neoplasms (5)  ·  Endocrine System Diseases (5)  ·  Gonadal Disorders (5)  ·  Ovarian Diseases (5)

Interventions

Palliative Care (2)  ·  68Ga-DKFZ-PSMA-11 (1)  ·  Bupropion (1)  ·  Doxycycline (1)  ·  FAPI-46 (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Metformin (1)  ·  gallium 68 PSMA-11 (1)

Sponsors

Albert Einstein College of Medicine (1)  ·  City of Hope Medical Center (1)  ·  Gynecologic Oncology Group (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Maria Sklodowska-Curie National Research Institute of Oncology (1)  ·  NRG Oncology (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

United States (7)

Top investigators

Debra Barton (1)  ·  Jennifer Johnson, MD, PhD (1)  ·  Jeremie Calais, MD (1)  ·  Lilie L Lin (1)  ·  Michael Cibull (1)  ·  Nicole Nevadunsky (1)  ·  Thanh Dellinger, MD (1)

Results publications

PMID 34882500, PMID 36512649, PMID 41101974

NIH funding

P30CA013330 (1), U10CA180868 (1), UG1CA189867 (1)